Home » Topics » BioWorld Science, Endocrine/metabolic

BioWorld Science, Endocrine/metabolic
RSS

Alinea announces Series A financing

Oct. 24, 2005

Prostanoid EP2 receptor agonists for gynecological disorders claimed in recent Pharmagene patent

Oct. 21, 2005

Biopure updates status of Hemopure development program

Oct. 21, 2005

Novel antidiabetic agents reported in recent patent literature

Oct. 20, 2005

New agents for treating obesity disclosed in recent AstraZeneca patent

Oct. 20, 2005

Approvable letter for Pargluva

Oct. 20, 2005

Ghrelin: a novel therapeutic approach for COPD-associated cachexia

Oct. 20, 2005

Phase I data on teverelix for reproductive use

Oct. 20, 2005

FR-167356's potential for clinical application in osteoporosis

Oct. 20, 2005

Simvastatin clinically beneficial for PCOS

Oct. 20, 2005

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 20, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for May 19, 2026
WHO declares Ebola outbreak a public health emergency of international concern
BioWorld
The threat posed by the Ebola outbreak in the Democratic Republic of Congo has intensified, with the confirmation that it is caused by the Bundibugyo species of...
Nxera Pharma prepares and tests new GPR17 antagonists
BioWorld Science
Nxera Pharma UK Ltd. has identified new uracil nucleotide/cysteinyl leukotriene receptor (GPR17; P2Y-Like) antagonists potentially useful for the treatment of...
Regeneron’s fianlimab lags in melanoma, does $2.3B deal with Parabilis
BioWorld
Regeneron Pharmaceuticals Inc. stuck with the tradition of releasing bad news on Friday afternoon and good news on Monday morning with a pair of announcements...